Mar 29, 2022
Today’s special guest, Dr. Subir Roy, Takeda’s Associate Director of Global Medical Affairs, has been at the intersection of pharma, commercial strategy, data, and technology helping drive greater results in drug development, commercialization, and patient outcomes.
He believes that unifying siloed data from patients, providers, and other healthcare stakeholders will be like striking the mother lode for life sciences companies. Eureka effects are waiting to be unleashed by the insights now hidden by fragmented patient data.
Joining Dr. Roy on today’s show is Dr. Anupam Kulkarni, Associate Director, Life Sciences, at Innovaccer. Before joining Innovaccer,, Dr. Kulkarni was at Roche and played an integral role in one of the fastest drug-to-market releases in India.
Here's what they discussed.